Coronary Artery Disease - 10/02/13
Doi : 10.1016/j.pop.2012.12.001
Michele A. Hanson, MD a, ⁎ 
, Mohammad Tariq Fareed, MD a, Sandra L. Argenio, MD b, Akochi O. Agunwamba, MD a, Teresa R. Hanson c
, Mohammad Tariq Fareed, MD a, Sandra L. Argenio, MD b, Akochi O. Agunwamba, MD a, Teresa R. Hanson c a Department of Family Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
b Department of Family Medicine, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
c Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA
Corresponding author.Résumé |
Coronary artery disease (CAD) is the leading cause of death worldwide. There are several presenting clinical syndromes, including sudden cardiac death. Risk factor analysis can help the primary care provider identify patients who may need more extensive evaluation or treatment. Treatment may be medical or surgical and depends on the individual patient’s comorbidities and preferences. In the future, growth of new blood vessels or cardiac cells may aid in the treatment of CAD.
Le texte complet de cet article est disponible en PDF.Keywords : Angina, Aspirin, Ischemia, Troponin
Plan
© 2013
Elsevier Inc. Tous droits réservés.
Vol 40 - N° 1
P. 1-16 - mars 2013 Retour au numéro
Article précédent
- Preface
- Robert D. Sheeler
- Heart Failure : Clinical Problem and Management Issues
- John M. Nicklas, Barry E. Bleske, Richard Van Harrison, Robert V. Hogikyan, Yeong Kwok, William E. Chavey
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?